Saturday, September 5Dedicate to Right News
Shadow

Tag: Beximco Pharma

Beximco Pharma and NSU partnership in advancing pharmaceutical research

Beximco Pharma and NSU partnership in advancing pharmaceutical research

Breaking News, Business
Beximco Pharmaceuticals PLC and the Department of Pharmaceutical Sciences of North South University (NSU) have reaffirmed their commitment to advancing pharmaceutical research, innovation and career development through their ongoing academic-industry collaboration.The partnership was formalised through a Memorandum of Understanding (MoU) signed last year, with the objective of creating opportunities for students to gain practical research experience and contribute to the development of Bangladesh’s pharmaceutical sector. Under the MoU, Beximco Pharma has been providing financial support and access to its world-class research facilities to selected MPharm students of NSU to facilitate their thesis projects on specific research topics.A small ceremony was held yesterday at Beximco Ph...
Beximco Pharma Introduces Affordable Generic for Breakthrough Cystic Fibrosis Treatment

Beximco Pharma Introduces Affordable Generic for Breakthrough Cystic Fibrosis Treatment

Breaking News, Health
Beximco Pharmaceuticals Ltd., one of Bangladesh’s leading pharmaceutical companies, has announced the global launch of Triko, a highly affordable generic version of Trikafta—the breakthrough triple-combination therapy for cystic fibrosis (CF) developed by Vertex Pharmaceuticals (USA). Cystic fibrosis is a rare, life-threatening genetic disorder that severely limits life expectancy. Worldwide, around 189,000 people are estimated to live with CF, yet only 60% are diagnosed and fewer than 27% receive treatment due to the exorbitant cost of the original therapy. Against this backdrop, a group of mothers of children with CF launched a community-led global buyers’ club to help patients access Beximco Pharma’s affordable generic version, unveiled as Triko, during the North American Cystic Fibro...